In this month’s article in Journal of Neurosurgery: Pediatrics, Mark Kieran and colleagues studied the frequency of brain imaging (through MRI) a patient receives to evaluate how often tumors recurred.  They found that at either 2 or 5 years of recurrence-free survival there were no clinical symptoms or mortality observed in the patient population studied, proposing a reduction in the number of MRI scans a patient receives from 10 to 5, thus reducing the psychological and financial impact of post-operative care.